Research programme: anti-inflammatory biologics topical - Rogne BioscienceAlternative Names: C 15; Chemerin 15; RON-2315
Latest Information Update: 16 Jul 2016
At a glance
- Originator University of Oxford
- Developer Rogne Bioscience; University of Oxford
- Class Peptides
- Mechanism of Action Immunosuppressants; Interleukin 12 inhibitors; Interleukin 23 inhibitors; NF-kappa B modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Psoriasis
- No development reported Cardiovascular disorders